Next-generation Sequencing Library Preparation Market Size & Growth Forecast 2027–2036, By Segments (Application, Sequencing Type, End Use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Application Segment Analysis: Drug & Biomarker Discovery (Largest Segment) vs Disease Diagnostics (Fastest-Growing Segment)

The drug & biomarker discovery segment accounted for the largest market share at 61.98% in 2026, driven by the growing use of next-generation sequencing to identify molecular targets, characterize disease mechanisms, and discover biomarkers that can support therapeutic development. Library preparation is a critical step in these workflows because it enables the conversion of complex genomic material into sequencing-ready libraries with the quality and characteristics required for downstream analysis. Increasing demand for precision medicine and molecularly informed drug development is encouraging researchers to incorporate sequencing into early-stage discovery programs. The ability to analyze genetic variation, gene expression, and other molecular characteristics also supports the identification and validation of potential biomarkers, reinforcing a dominant next-generation sequencing library preparation market share in 2026.

The disease diagnostics segment is expected to grow at the fastest pace, capturing an increasing market share in 2026, supported by increasing adoption of genomic testing for the detection, classification, and monitoring of diseases. Advances in sequencing technologies are enabling more comprehensive analysis of genetic alterations and molecular signatures, supporting applications across inherited disorders, oncology, infectious diseases, and other diagnostic areas. The growing emphasis on personalized healthcare is further increasing demand for diagnostic approaches capable of providing detailed molecular information for treatment selection and disease management. Improvements in sequencing accuracy, workflow automation, and library preparation efficiency are helping make NGS-based diagnostics more practical across clinical settings, expanding market share for the disease diagnostics application segment throughout 2026.

Sequencing Type Segment Analysis: Targeted Genome Sequencing (Largest Segment) vs Whole Genome Sequencing (Fastest-Growing Segment)

The targeted genome sequencing segment accounted for the largest market share at 61.45% in 2026, supported by its ability to focus sequencing resources on specific genes, genomic regions, or clinically relevant targets. Targeted sequencing can provide efficient analysis of selected genomic areas while generating focused datasets that are easier to interpret for research and diagnostic purposes. Its suitability for applications such as disease-associated variant analysis, biomarker research, and targeted molecular profiling continues to support widespread adoption. The approach can also offer practical advantages when researchers require detailed information about defined genomic targets rather than comprehensive analysis of the entire genome. Continued improvements in target enrichment and library preparation workflows are further enhancing the efficiency and reliability of targeted genome sequencing to maintain a major next-generation sequencing library preparation market share in 2026.

The whole genome sequencing segment is anticipated to grow at the fastest pace, capturing a greater market share in 2026, driven by increasing demand for comprehensive genomic analysis across research, clinical, and precision medicine applications. Whole genome sequencing enables broad characterization of genetic variation across coding and non-coding regions, providing a more complete view of an individual's genomic profile. Growing interest in identifying previously unknown variants, understanding complex disease mechanisms, and supporting individualized healthcare is expanding the relevance of whole genome approaches. Advances in sequencing platforms, computational analysis, and library preparation are helping improve workflow efficiency and data interpretation, making comprehensive genomic analysis increasingly accessible. As research and clinical programs place greater emphasis on broad genomic characterization, market share for whole genome sequencing library preparation is expected to strengthen in 2026.

End Use Segment Analysis: Academic and Research Institutions (Largest Segment) vs Pharmaceutical and Biotechnology Companies (Fastest-Growing Segment)

The academic and research institutions segment accounted for the largest market share at 39.52% in 2026, reflecting the extensive use of next-generation sequencing library preparation in fundamental genomics, molecular biology, disease research, and biomarker studies. Research institutions use sequencing workflows to investigate genetic variation, gene regulation, disease pathways, and other biological processes across diverse research programs. The increasing availability of sequencing technologies and specialized library preparation methods is enabling researchers to conduct increasingly sophisticated genomic investigations. Academic research also contributes to the development and validation of new sequencing applications, supporting continued market share demand for flexible and reliable library preparation workflows in 2026.

The pharmaceutical and biotechnology companies segment is expected to grow at the fastest pace, expanding its next-generation sequencing library preparation market share in 2026, driven by the increasing integration of genomic information into drug discovery, biomarker development, therapeutic stratification, and precision medicine programs. These companies use next-generation sequencing to investigate disease biology, identify molecular targets, evaluate treatment response, and support the development of personalized therapies. Growing emphasis on data-driven drug development is increasing the value of high-quality sequencing workflows capable of generating reproducible molecular information. Advances in sequencing-based biomarker analysis and the expanding use of genomic data across pharmaceutical research are further encouraging adoption of library preparation technologies, driving strong market share growth for this end-use segment in 2026.